Region — US. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Ceramides
Research reference — not for sale

Ceramides

A
lead outcome
Barrier repair / TEWL reduction…
grades vary by outcome ↓
Small molecule (non-peptide)
also called — ceramide NP · ceramide AP · ceramide EOP · ceramide 3 · ceramide 6-II · ceramide 1
skin appearance (cosmetic)barrier supporthydrationsoothing (appearance of dryness)

Ceramides are lawful cosmetic ingredients worldwide and among the best-tolerated of all skincare actives (naturally present in skin, no documented pregnancy concerns). Vallydia uses them in barrier-support formulations designed with the cholesterol and fatty-acid partners that the evidence shows are necessary for function. Reference science below includes medical (atopic dermatitis) studies for mechanism context; only cosmetic appearance/comfort use is relevant to the sellable product.

In brief

Ceramides are the lipid molecules that make up roughly half of the skin's barrier by mass. Topical ceramide-dominant formulations have strong, well-replicated evidence for reducing transepidermal water loss and improving hydration — but with one crucial caveat: they work as barrier lipids only when combined with cholesterol and free fatty acids in balanced ratios (roughly 3:1:1). Ceramides alone in a poor vehicle underperform, and an incorrect lipid ratio can even temporarily disrupt the barrier. Properly formulated, they are a cornerstone barrier-repair ingredient, exceptionally gentle, and pregnancy-friendly.

Legal standing, by region
International
Lawful cosmetic ingredient

Topical ceramides (ceramide NP, ceramide AP, ceramide EOP, and related sphingolipids and pseudo-ceramides) are lawful cosmetic ingredients globally, including EU (Regulation (EC) 1223/2009). CosIng-listed by species. No concentration ceiling. Naturally present in human skin; widely used at 0.05–2% depending on species and formulation. Not a restricted or controlled substance in any major market.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Barrier repair / TEWL reduction (ceramide-dominant formula)
Efficacy depends heavily on formulation — ceramides work as barrier lipids only when combined with cholesterol and free fatty acids in balanced ratios (see mechanism). Isolated ceramides in a poor vehicle underperform.
Multiple RCTs and controlled trials; multicenter study n=312 (4-week ceramide-enriched regimen, SCORAD −61.2%); 2019 qualitative review of 12 clinical studies; 2024-2025 controlled trials showing structurally skin-identical ceramide NP/AP/EOP formulations reduce transepidermal water loss and raise stratum corneum lipid content · Measurable reduction in transepidermal water loss and improved skin hydration, typically within 1–2 weeks of consistent twice-daily use
A
Adjunct in atopic dermatitis / eczema-prone dry skin (appearance & comfort)
Atopic dermatitis is a medical condition — ceramide cosmetics are barrier-supportive adjuncts, not treatments. Persistent or severe cases need a dermatologist.
Multiple interventional studies in mild-to-moderate atopic dermatitis; ceramide-dominant formulations achieve ~45–60% clinical success (IGA clear/almost clear) in 3–8 week studies; physiological-lipid formulations (MVE+GL) outperform simple emollients in barrier integrity · Reduced dryness, itch, and roughness; improved barrier integrity as an adjunct to (not replacement for) medical treatment
A
Aged / menopausal skin barrier (hydration & smoothness appearance)
Fewer large trials specific to aged skin than to atopic dermatitis; effect is barrier/hydration-mediated, not collagen-building
Clinical research in elderly individuals showing high-concentration ceramide formulations improve hydration and barrier function; consistent with the age-related decline in endogenous ceramide content · Improved skin hydration and the appearance of smoother skin
B
Oral ceramide supplementation (skin hydration)
Oral use is outside cosmetic scope and much less established than topical. Not relevant to Vallydia's sellable topical products.
Small open-label studies (e.g. rice-derived ceramide supplementation n=50) suggesting hydration benefit; evidence far thinner than for topical · Possible modest hydration improvement
C
Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • supports the appearance of a healthy, resilient-looking skin barrier
  • helps skin look and feel hydrated and comfortable
  • for the appearance of smoother, less-flaky skin
  • helps reduce the look of dryness and tightness
  • replenishes skin's feel of moisture
✕ Not allowed (medicinal)
  • repairs the skin barrier
  • treats eczema
  • treats atopic dermatitis
  • heals damaged skin
  • restores the lipid barrier
  • reduces inflammation
  • anti-inflammatory
  • cures dryness

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

Identity

Ceramides are a family of sphingolipids — waxy lipid molecules made of a sphingosine (or phytosphingosine) backbone linked to a fatty acid. They are one of the three main lipid classes of the skin's outermost layer (the stratum corneum), alongside cholesterol and free fatty acids, and constitute approximately 50% of the barrier's lipid mass. The stratum corneum contains 12+ distinct ceramide species, classified by molecular structure. The ones most used in skincare:

  • Ceramide NP (formerly Ceramide 3) — the most abundant, the primary structural barrier lipid.
  • Ceramide AP (Ceramide 6-II) — aids penetration; associated with anti-inflammatory activity.
  • Ceramide EOP (Ceramide 1) — an unusual ester-linked omega-hydroxy ceramide critical for organising the lamellar (layered) structure of the barrier; notably depleted in eczema.

Development & history

  • Identified as key stratum corneum lipids through skin-barrier research from the 1980s onward, as the "brick and mortar" model of the stratum corneum (corneocyte "bricks" in a lipid "mortar") became established.
  • Recognition that ceramide depletion drives dryness and barrier dysfunction (documented in atopic dermatitis and aged skin) motivated their use in barrier-repair cosmetics.
  • Synthetic "skin-identical" ceramides and pseudo-ceramides were developed to allow stable cosmetic formulation.
  • Now a cornerstone of the "barrier repair" category — the dominant skincare trend of the mid-2020s as the earlier "more actives" culture gave way to gentler, barrier-first routines.

Mechanism (as proposed)

The stratum corneum works as a permeability barrier because its lipids form organised lamellar (multi-layer) sheets between the skin cells, sealing water in and irritants out. Ceramides are the dominant structural component of those sheets. When ceramide content drops — through age, harsh products, over-exfoliation, or conditions like eczema — the lamellar structure is disrupted, transepidermal water loss rises, and skin becomes dry and reactive.

Topically applied ceramides can integrate into this lipid matrix and, in ceramide-deficient skin, help restore its organisation and reduce water loss. The single most important formulation principle: ceramides do not act alone. A healthy barrier is roughly 50% ceramides, 25% cholesterol, and 15% free fatty acids by lipid mass (commonly formulated near a 3:1:1 ceramide:cholesterol:fatty-acid ratio). Studies show that applying lipids in a physiologically balanced ratio restores the barrier, whereas an incorrect ratio can delay recovery or temporarily worsen it. This is why ceramide efficacy is a formulation property, not just an ingredient-presence property — the reason two products both listing "ceramides" can perform very differently.

Niacinamide is worth noting as a complementary partner: it boosts the skin's own synthesis of ceramides and fatty acids, so the two are frequently and sensibly combined.

Sources — 6 cited
01Elias PM, Wakefield JS. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2014.
02Meckfessel MH, Brandt S. The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. J Am Acad Dermatol. 2014; 71(1):177-84.
03Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis. 2008.
04Spada F, Barnes TM, Greive KA. Skin hydration is significantly increased by a cream formulated to mimic the skin's own natural moisturizing systems. Clin Cosmet Investig Dermatol. 2018.
05Qualitative review of 12 clinical studies on ceramide-containing formulations in barrier repair (2019).
06Multicenter study (n=312) — ceramide-enriched regimen; SCORAD reduction reference cited above.
Review status
Not yet reviewed

A credentialed reviewer (PharmD / PhD / MD) will be named before this entry is finalised. Until then, treat it as a working draft. Last updated 2026-07-08.

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Niacinamide (Vitamin B3)A
Small molecule (non-peptide)
Hyaluronic Acid (Sodium Hyaluronate)A
Polysaccharide
EctoinB
Small molecule (non-peptide)
GHK-Cu (Copper Tripeptide-1)B
Peptide
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.

Region — United States
ExploreRegisterCategoriesTrust & COAHow we grade
ShopCosmetic peptidesJournal
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.

Ceramides — evidence, uses & status · Vallydia